[1] Nicholson JK, onnelly J, Lindon JC, el al. Metabonomics: aplatfom for sludying drug toxicity and gene function [J]. NatRev Drug Discov, 2002;1:153-161. [2] 徐旻,林东海,刘昌孝,代谢组学研究现状与展望[J]. 2005;40:769-774. [3] Oliver SG. Yeast as a navigational aid in genome analysis[J].Microbiology, 1997; 143: 1483-1487. [4] Nicholson JK, Lindon JC, Holmes E. Metabonomics :under-standing the metabolic responses of living systems to pathophysi-ological stimuli via multivariate statistical analysis of biologicalNMR spectroscopic data[J]. Xenobiotica, 1999; 29: 1181-189. [5] Dunn WB, Bailey NJ, Johnson HE. Measuring the metabo-lome: current analytical technologies[J]. Analyst, 2005; 130:606-625 . [6] Fiehn O, Kloska S, Altmann T. Integrated studies on plant bi-ology using multiparallel techniques[J]. Curr Opin Botechnol, 2001;12:82-86. [7] Plumb RS, Granger JH, Stumpf CL, et al. A rapid screeningapproach to metabonomics using UPLC and oa-TOF mass spec-trometry: application to age, gender and diumal variation innommal Zucker obese rats and black, white and nude mice[J] .Analyst, 2005; 130:844-849. [8] Fiehn O, Kristal B, van OmmenB, el al, Establishing report-ing standards for metabolomic and metabonomic studies: a callfor participation[J]. Omics, 2006;10:158-163. [9] Jenkins H, Hardy N, Beckmann M, el al. A proposed frame-work for the description of plant metabolomics experiments andtheir resuls[J]. Nat Biotechnol, 2004;22:1601-1606. [10] AJ, Trygg J, GullbergJ, et al. Extraction and CC/MS analys-is of the human blood plasma metabolome[J]. Anal Chem,2005;77 :8086-8094. [11] Koek MM, Muilwijk B, van der Werf MJ, et al. Microbialmetabolomics with gas chromatography/mass spectrometry[J].Anal Chem, 2006;78:1272-1281. [12] Lindon JC, Nicholson JK, Holmes E, et al . Sunmary recom-mendations for standardization and reporting of metabolic analy-ses[J]. Nat Biotechnol, 2005 ;23:833-838. [13] Allen J, Davey HM, Broadhurst D, et al. High-throughputclassification of yeast mutants for functional genomics usingmetabolic footprinting[J]. Nat Biotechnol, 2003; 21:692-696. [14] Want EJ, O'Maille G, Smith CA, et al. Solvent-dependentmetabolite distribution, clustering, and protein extraction foserum profiling with mass spectrometry[J]. Anal Chem, 2006;78:743-752. [15] Akira K, Imachi M, Hashimoto T. Investigations into biochemical changes of genetic hypertensive rats using IH nuclear mag-netic resond metabnomics [J]. Hypertens Res, 2005;28:425-430. [16] 许国旺,杨军.代谢组学及其研究进展[J].色谱,2003;21 :316-320. [17] 赵剑宇,颜贤忠基于核磁共振的代谢组学研究进展[J].国外医学药学分册,2004;31:308-312. [18] Lenz EM, Wilson ID. Analytical strategies in metabonomics[J]. J Proteome Res, 2007 ;6:443-458. [19] Boemsen ко, Gatzek s, Imbert c, el al. Controlled proteinprecipitation in combination with chip-based nanospray infusionmass spectrometry .An approach for metabolomics profiling ofplasma[J]. Anal Chem, 2005 ;77:7255-7264. [20] Castrillo JI, Hayes A, MohammedS, el al. An optimized pru-tocol for metabolome analysis in yeast using direct infusion elec-trospray mass spectrometry [J]. Phytochemistry, 2003 ; 62: 929-937. [21] Allen J, Davey HM , Broadhurst D,et al. High-throughputclassification of yeast mutants for functional genomics usingmetabolic footprintinglJ J. Nat Biotechnol, 2003; 21: 692-696. [22] Scholz M, Gatzek s, Serling A, et al. Metabolite fingerprint-ing: detecting biological features by independentcomponentanalysis[J]. Bioinfomnatics, 2004 ;20: 24472454. [23] Hirai MY, Yano M, Goodenowe DB, et al . Integration of tran-scriptomics and metabolomics for understanding of global re-sponses to nutritional stresses in Arabidopsis thaliana[J]. ProcNatl Acad Sci USA, 2004; 101: 10205-10210. [24] Plumb RS, Sumpf CL, Corenstein Mv, et al. Metaboromics:the use of electrospray mass spectrometry coupled to reversed-phase liquid ehromratogruphy shkown polential for the screening ofrat rine in drug development(]. Rapid Cummun Mass Spec-trom, 20021 161 1991-1996. [25] Wilson ID, Plumb R, Cranger J, et al. HPLC MS basedmethodl for the study of metalonomics[J, J Chromnatogr B An-alyt Technol Biomed Life Sci, 2005;817;67-76. [26] Phuan-Tuan H, Kaskavelis L, Daykin CA, el al. Method de-velopment in high-performance liquid chromatography for high-throughput profiling and metabononic studies of biofluid samples[J]. J Chromatography B, 2003;789:283-301. [27] Plumb RS, Johnson KA, RainvilleP, et al. úPLC/MS: a newapproach for generating molecular fragment information for bio-maker stru ture elucidation [J]. Rapid Commun Mass Spec-trom, 2006; 20:2234. [28] Lafaye A, Junot c, Ramounet-Le GB, et al. Metabolite profil-ing in rat urine by liquid chromatographylelectrospray ion trapmass spectrometry: Application to the study of heavy metal tox-icity[J]. Rapid Commun Mass Speetrom, 2003; 17:2541-2549. [29] Snbatine MS, Liu E, Morrow DA, et al. Metabolomic identifi-cation of novel biomarkers of myocardial ischemia[J]. Circula-tion, 2005;112:3868-3875. [30] Raiville PD, Stunpf CL, Shockoor JP, et al. Novel applica-tion of reversed-phase UPLC-oaTOF-MS for lipid analysis incomplex biological mixtures: a now tool for lipidomics[J]. JProteome Res, 2007 ;6:552-SS8. [31] Yin P, Zhao X, LiQ, el al. Metalonomics Study of Intestinal Fistulas Based on Ultraperfomance Liquid ChromatographyCoupled with Q-TOF Mass Spectromelry (UPLC/Q-TOF MS)[J]. J Proteome Res, 2006;5:2135-2143. [32] Viant MR, Pincetich CA, Hinton DE, et al . Toxic actions ofdinoseb in medaka (Oryzias latipes) embryos as detemmined byin vivo 'p NMR, HPLC-UV and 'H NMR metabolomics J].Aquatic Toxicology , 2006; 76: 329-342. [33] Lenz EM, Bright J, Knight R, et al . Cyclosporin A-inducedchanges in endogenous metabolites in rat urine: a metabonomicinvestigation using high field 'H NMR spectroscopy, HPLC-TOF/MS and chemometrics[J]. J Pharm Biomed Anal, 2005 ;35:599-608. [34] Williams RE, Major H, Lock EA, et al. D-Serine-inducednephrotoxicity: a HPLC-TOF/MS-based metabonomics approach[J]. Toxicology, 2005;207:179-190. [35] YangJ, ZhaoX, LiuX, et al. High Performance Liquid Chro-matography-Mass Spectrometry for Metabonomics: Potential Bio-markers for Acute Deterioration of Liver Function in ChronicHepatitis B[J]. J Proteome Res, 2006;5:554-561. [36] Dettmer K, Aronov PA, Hammock BD.Mass spectrometry-based metabolomics[J]. Mass Spectrom Rev, 2007;26:51-78. [37] Adahchour M, Brandt M, Baier HU. Comprehensive two-di-mensional gas chromatography coupled to a rapid-scanning qua-drupole mass spectrometer: principles and applications[J]. JChromatogr A, 2005; 1067:245-254. [38] O'HaganS, Dunn WB, Knowles JD, et al. Closed-loop, mul-tiobjective optimization of two-dimensional gas chromatography/ma8s spertrometryfor serurI metabolomics J]. Anal Chem,2007;79:464-476. [39] Kuhara T. Gas chromatographic-mass spectrometric urinarymetabolome analysis to study mutations of inbom errors of me-tabolism[J]. Mass Spectrom Rev, 2005;24:814-827. [40] OhdoiC, Nyhan WL, Kuhara T. Chemical diagnosis of Lesch-Nyhan syndrome using gas chromatography-mass spectrometrydeltection[J]. J Chromatography B, 2003;792;123-130. [41] Terabe S. Metabolome analysis by capillary electrophoresis-mass spectromelry[J]. J Chromatogr A, 2007; 1168: 237-246. [42] Ramautar R, Jong GJ, Demirci A. Capillary electrophoresis inmetabolomics[J]. Trends Analyt Chem, 2006; 25:455-466. [43] Reo NV. NMR-based metabolomics[J]. Drug Chem Toxicol,2002;25:375-382. [44] Dumas M, Maibaum EC, Teague c, et al. Assessment of ana-lytical reproducibility of (1)H NMR spectroscopy based metab)-nomics for large-scale epidemiological research: the INTERMAP study[J]. Anal Chem, 2006 ;78:2199-2208. [45] Sandusky P, Raftery D. Use of semiselective TOCSY and thepearson correlation for the metabonomic analysis of biofluid mix-tures: aplication to urine[J]. Anal Chem, 2005 ;77:7717-7723. [46] Wind RA, Hu JZ, Majors PD. Slow-MAS NMR: A new techn-ology for in vivo metalolomic studies[J]. Drug Discov Today:Technol, 2005;2: 291-294. [47] Clayton TA, Lindon JC, Cloarec 0, et al. Pharmaco-metabo-nomic phenolyping and personalized drug treatmen[J]. Nature,2006;440: 1073-1077. [48] Lindon JC, Keun HC, Ebbels TM, et al. The consortium formetabonomic toxicology (COMET) : aims, activities and achie-vements[J]. Pharmacogenomics, 2005 ;6:691-699. [49] Brindle JT, Henrik A, Elaine H, et al . Nature Medicine[J].Nat Med, 2002;8: 1439-1444. [50] Bo llardME, Stanley EG, Lindon JC. NMR-based metabonomicapproaches for evaluating physiological influences on biofluidcomposition[J]. NMR Biomed, 2005;18: 143-162. [51] Atherton HJ, Bailey NJ, Zhang W, et al. A combined IHNMRspectroscopy andmass spectrometry-based metabolomicstudy of the PPAR null mutant mouse defines profound systemicchanges in metabolism linked to the metabolic syndrome[J].Physiol Genomics, 2006;27: 178-186. [52] Crockford DJ, Holmes E, Lindon JC, et al. Statistical het-erospectroscopy, an approach to the integrated analysis of NMRand UPLC-MS data sels: application in metabonomic toxicologystudies[J]. Anal Chem, 2006 ;78:363-371. [53] Willians R, Lenz, EM, Wilson AJ, et al. A multi-analyticalplatform approach to the metabonomic analysis of plasma fromnormal and zucker (fa/fa) obxese rats[J]. Mol Biosyst, 2006;2: 74-183. [54] Goodacre R J. Making sense of the metalolome using evolution-ary computation: seeing the wood with the trees [J]. Exp Bot,2005 ;56:245-254. [55] Shulaev V. Metalolomics technology and bioinfonnatics[J].Brief Bioinforn, 2006;7:128-139. [56] SmithCA, Want EJ, O'Maille G, et al. XCMS: processingmass spectrometry data for metabolite profiling using nonlinearpeak alignent, matching, and idenifiation[J], Anal Chem,2006;78:779-787. [57] Eriksson L, Antti H, Gotfries J, et al . Using chemometrics fornavigating in the large data sets of genomics, proteomics, andmetabonomics(gpm)[J].Anal Bioanal Chem, 2004; 380:419-429. [58] Trygg J, Holmes E, Lundstedt T. Chemometrics in Metabo-nomics[J]. J Proteome Res. 2007;6:469-479. [59] Keun HC, Ebbels TM, Bollard ME, et al. Ceometric trajectoryanalysis of metabolic responses to toxicity can define treatmentspecific profiles[J]. Chem Res Toxicol, 2004;17:579-587. [60] Williams RE, Lenz EM, Lowden JS, et al . The metabonomics ofaging and development in the rat: an investigation into the effectof age on the profile of endogenous metabolites in the urine ofmale rats using 'H NMR and HPLC-TOF MS[J]. Mol Biosyst,2005;1:166-175. [61] Bollard ME, Keun HC, Beckonert 0, et al . Comparative meta-bonomics of differential hydrazine toxicity in the rat and mouse[J]. Toxicol Appl Pharmacol, 2005 ;204:135-I51. [62] Styczynski MP, Moxley JF, Tong LV, et al. Systematic Identi-fication of Conserved Metabolites in GC/MS Data for Metabolo-mics and Biomarker Discovery[J]. Anal Chem, 2007;79:966-973. [63] Schauer N, Seinhauser D, Strelkov s, et al. GC-MS librariesfor the rapid ident ifiation of metabklites in complex biologicalsamples[J]. FEBS Lett, 2005;579:1332-1337. [64] Halket JM, Wateman D, Przyborowska AM, et al. Chemicalderivatization and mass spectral libraries in metabolic profilingby GC/MS and LC/MSMS[J]. J Exp Bot, 2005;56:219-243. [65] Fridman E, PicherskyE.Metabolomics,genomics, pro-teomics, and the identification of enzymes and their substratesand prodlucts[J]. Curr Opin Plant Biol, 2005;8:242-248. . |